These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 18455284)

  • 41. Allogeneic stem cell transplantation is able to induce long-term remissions in angioimmunoblastic T-cell lymphoma: a retrospective study from the lymphoma working party of the European group for blood and marrow transplantation.
    Kyriakou C; Canals C; Finke J; Kobbe G; Harousseau JL; Kolb HJ; Novitzky N; Goldstone AH; Sureda A; Schmitz N
    J Clin Oncol; 2009 Aug; 27(24):3951-8. PubMed ID: 19620487
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Risk factors for relapse after allogeneic transplantation in acute myeloid leukemia.
    Ossenkoppele GJ; Janssen JJ; van de Loosdrecht AA
    Haematologica; 2016 Jan; 101(1):20-5. PubMed ID: 26721801
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Matched unrelated or matched sibling donors result in comparable survival after allogeneic stem-cell transplantation in elderly patients with acute myeloid leukemia: a report from the cooperative German Transplant Study Group.
    Schetelig J; Bornhäuser M; Schmid C; Hertenstein B; Schwerdtfeger R; Martin H; Stelljes M; Hegenbart U; Schäfer-Eckart K; Füssel M; Wiedemann B; Thiede C; Kienast J; Baurmann H; Ganser A; Kolb HJ; Ehninger G
    J Clin Oncol; 2008 Nov; 26(32):5183-91. PubMed ID: 18768435
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Acute myeloid leukemia].
    Tabuchi K
    Gan To Kagaku Ryoho; 2007 Feb; 34(2):156-61. PubMed ID: 17301520
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identical outcome after autologous or allogeneic genoidentical hematopoietic stem-cell transplantation in first remission of acute myelocytic leukemia carrying inversion 16 or t(8;21): a retrospective study from the European Cooperative Group for Blood and Marrow Transplantation.
    Gorin NC; Labopin M; Frassoni F; Milpied N; Attal M; Blaise D; Meloni G; Iori AP; Michallet M; Willemze R; Deconninck E; Harousseau JL; Polge E; Rocha V
    J Clin Oncol; 2008 Jul; 26(19):3183-8. PubMed ID: 18506024
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Place of HSCT in treatment of childhood AML.
    Klingebiel T; Reinhardt D; Bader P;
    Bone Marrow Transplant; 2008 Oct; 42 Suppl 2():S7-9. PubMed ID: 18978749
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Donor leukocyte infusions in myeloid malignancies: new strategies.
    Porter DL; Antin JH
    Best Pract Res Clin Haematol; 2006; 19(4):737-55. PubMed ID: 16997180
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reduced intensity and non-myeloablative allogeneic stem cell transplantation in children and adolescents with malignant and non-malignant diseases.
    Satwani P; Morris E; Bradley MB; Bhatia M; van de Ven C; Cairo MS
    Pediatr Blood Cancer; 2008 Jan; 50(1):1-8. PubMed ID: 17668859
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fludarabine and cytarabine combined chemotherapy followed by transfusion of donor blood stem cells for treating relapse of acute leukaemia after allogeneic haematopoietic stem cell transplantation.
    You Y; Li QB; Chen ZC; Li WM; Xia LH; Zhou H; Zou P
    Chin Med J (Engl); 2008 Sep; 121(18):1770-4. PubMed ID: 19080355
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Unfavorable-risk cytogenetics in acute myeloid leukemia.
    Hong WJ; Medeiros BC
    Expert Rev Hematol; 2011 Apr; 4(2):173-84. PubMed ID: 21495927
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Allogeneic stem cell transplantation in adults with acute lymphoblastic leukaemia].
    Fløisand Y; Brinch L; Dybedal I; Gedde-Dahl T; Heldal D; Holme PA; Egeland T; Tjønnfjord GE
    Tidsskr Nor Laegeforen; 2008 Nov; 128(22):2563-6. PubMed ID: 19023351
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Timed sequential induction chemotherapy and risk-adapted postremission therapy for acute myelogenous leukemia.
    Kalaycio M; Advani A; Pohlman B; Sekeres M; Tripp B; Rybicki L; Sobecks R
    Am J Hematol; 2008 Nov; 83(11):831-4. PubMed ID: 18756545
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Risk-stratified therapy and the intensive use of cytarabine improves the outcome in childhood acute myeloid leukemia: the AML99 trial from the Japanese Childhood AML Cooperative Study Group.
    Tsukimoto I; Tawa A; Horibe K; Tabuchi K; Kigasawa H; Tsuchida M; Yabe H; Nakayama H; Kudo K; Kobayashi R; Hamamoto K; Imaizumi M; Morimoto A; Tsuchiya S; Hanada R
    J Clin Oncol; 2009 Aug; 27(24):4007-13. PubMed ID: 19620491
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Alternative donor transplants for high-risk acute myeloid leukemia.
    Gupta V
    Curr Opin Hematol; 2008 Mar; 15(2):115-20. PubMed ID: 18300757
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment of adult AML with t(6;11)(q27;q23) by allogeneic hematopoietic SCT in the first CR.
    Tamai H; Yamaguchi H; Takahashi S; Tojo A; Hamaguchi H; Kobayashi T; Akiyama H; Sakamaki H; Okumura H; Nakao S; Arai A; Miura O; Tajika K; Inokuchi K; Dan K
    Bone Marrow Transplant; 2008 Oct; 42(8):553-4. PubMed ID: 18622415
    [No Abstract]   [Full Text] [Related]  

  • 56. Pediatric standard-risk AML with fully matched sibling donors: to transplant in first CR or not?
    Gassas A; Afzal S; Ishaqi MK; Finkelstein-Shechter T; Rojas M; Dupuis A; Sung L; Doyle J
    Bone Marrow Transplant; 2008 Sep; 42(6):393-6. PubMed ID: 18587434
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pretransplant metabolic distress predicts relapse of acute myeloid leukemia after allogeneic stem cell transplantation.
    Dietrich S; Radujkovic A; Stölzel F; Falk CS; Benner A; Schaich M; Bornhäuser M; Ehninger G; Krämer A; Hegenbart U; Ho AD; Dreger P; Luft T
    Transplantation; 2015 May; 99(5):1065-71. PubMed ID: 25340610
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Pilot Study of Allogeneic Hematopoietic Stem Cell Transplantation for Intermediated-risk Acute Myeloid Leukemia Patients.
    Oh MJ; Shin DY; Koh Y; Hong J; Kim I; Yoon SS; Byun JM
    In Vivo; 2021; 35(1):617-622. PubMed ID: 33402517
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.
    Harker-Murray PD; Thomas AJ; Wagner JE; Weisdorf D; Luo X; DeFor TE; Verneris MR; Dusenbery KE; MacMillan ML; Tolar J; Baker KS; Orchard PJ
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):685-92. PubMed ID: 18489994
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of FAB classification on predicting outcome in acute myeloid leukemia, not otherwise specified, patients undergoing allogeneic stem cell transplantation in CR1: An analysis of 1690 patients from the acute leukemia working party of EBMT.
    Canaani J; Beohou E; Labopin M; Socié G; Huynh A; Volin L; Cornelissen J; Milpied N; Gedde-Dahl T; Deconinck E; Fegueux N; Blaise D; Mohty M; Nagler A
    Am J Hematol; 2017 Apr; 92(4):344-350. PubMed ID: 28052366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.